Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bharat H Joshi

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Immunotherapy|July 20, 2010
IL-13 receptor-alpha2: a novel target for cancer therapyBharat H Joshi, Raj K Puri
Protein Expression and Purification|January 12, 2005
Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coliBharat H Joshi, Raj K Puri
Current Molecular Medicine|August 20, 2009
Tumor immunologyBharat H Joshi, Raj K Puri
Journal of Translational Medicine|April 12, 2011
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancerToshio Fujisawa, Bharat H Joshi, Raj K Puri
Croatian Medical Journal|September 2, 2003
Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion proteinBharat H Joshi, Pamela Leland, Raj K Puri
International Journal of Cancer|August 23, 2011
IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancerToshio Fujisawa, Bharat H Joshi, Raj K Puri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxinBharat H Joshi, Koji Kawakami, Pamela Leland, et al.
Cytokine|June 20, 2015
Targeting of IL-4 and IL-13 receptors for cancer therapyAkiko Suzuki, Pamela Leland, Bharat H Joshi, et al.
International Journal of Cancer|May 18, 2010
Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabineToshio Fujisawa, Hideyuki Nakashima, Atsushi Nakajima, et al.
Cancer Medicine|September 12, 2014
Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the diseaseBharat H Joshi, Pamela Leland, Samir Lababidi, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Immunotherapy|July 20, 2010
IL-13 receptor-alpha2: a novel target for cancer therapyBharat H Joshi, Raj K Puri
Protein Expression and Purification|January 12, 2005
Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coliBharat H Joshi, Raj K Puri
Current Molecular Medicine|August 20, 2009
Tumor immunologyBharat H Joshi, Raj K Puri
Journal of Translational Medicine|April 12, 2011
Histone modification enhances the effectiveness of IL-13 receptor targeted immunotoxin in murine models of human pancreatic cancerToshio Fujisawa, Bharat H Joshi, Raj K Puri
Croatian Medical Journal|September 2, 2003
Identification and characterization of interleukin-13 receptor in human medulloblastoma and targeting these receptors with interleukin-13-pseudomonas exotoxin fusion proteinBharat H Joshi, Pamela Leland, Raj K Puri
International Journal of Cancer|August 23, 2011
IL-13 regulates cancer invasion and metastasis through IL-13Rα2 via ERK/AP-1 pathway in mouse model of human ovarian cancerToshio Fujisawa, Bharat H Joshi, Raj K Puri
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxinBharat H Joshi, Koji Kawakami, Pamela Leland, et al.
Cytokine|June 20, 2015
Targeting of IL-4 and IL-13 receptors for cancer therapyAkiko Suzuki, Pamela Leland, Bharat H Joshi, et al.
International Journal of Cancer|May 18, 2010
Targeting IL-13Rα2 in human pancreatic ductal adenocarcinoma with combination therapy of IL-13-PE and gemcitabineToshio Fujisawa, Hideyuki Nakashima, Atsushi Nakajima, et al.
Cancer Medicine|September 12, 2014
Interleukin-4 receptor alpha overexpression in human bladder cancer correlates with the pathological grade and stage of the diseaseBharat H Joshi, Pamela Leland, Samir Lababidi, et al.
Pageof 5